Psychiatric treatment in primary care patients with anxiety disorders: A comparison of care received from primary care providers and psychiatrists

American Journal of Psychiatry

Volumn 164, Issue 2, 2007, Pages 276-282

  Weisberg, Risa B ^a   Dyck, Ingrid ^b   Culpepper, Larry ^b   Keller, Martin B ^b  

^a BROWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUSPIRONE; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; ETHNIC GROUP; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOTHERAPY; SCREENING;

ADULT; AMBULATORY CARE; ANXIETY DISORDERS; ATTITUDE TO HEALTH; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; PSYCHIATRY; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; SEROTONIN UPTAKE INHIBITORS; TREATMENT REFUSAL;

EID: 33847261025     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.2.276     Document Type: Article

References (26)

1. Price D, Beck A, Nimmer C, Bensen S: The treatment of anxiety disorders in a primary care setting. Psychiatr Q 2000; 7:31-45
2. Shear MK, Schulberg HC: Anxiety disorders in primary care. Bull Menninger Clin 1995; 59(suppl A):A73-A85
3. Beardsley RS, Gardocki GJ, Larson DB, Hidalgo J: Prescribing of psychotropic medication by primary care physicians and psychiatrists. Arch Gen Psychiatry 1988; 45:1117-1119
4. Weiller E, Bisserbe JC, Maier W, Lecrubier Y: Prevalence and recognition of anxiety syndromes in five European primary care settings. Br J Psychiatry 1998; 173(suppl 34):18-23
5. Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58:55-61
6. Fifer SK, Mathias SD, Patrick DL, Mazonson PD, Lubeck DP, Buesching DP: Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 1994; 51:740-750
7. Nisenson LG, Pepper CM, Schwenk TL, Coyne JC: The nature and prevalence of anxiety disorders in primary care. Gen Hosp Psychiatry 1998; 20:21-28
8. Roy-Byrne PP, Stein MB, Russo J, Mercier E, Thomas R, McQuaid J, Katon WJ, Craske MG, Bystritsky A, Sherbourne CD: Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry 1999; 60:492-499
9. Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P: Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 1996; 53:889-895
10. Simon G, Ormel J, VonKorff M, Barlow W: Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995; 152:353-357
11. Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK: Physician office visits of adults for anxiety disorders in the United States, 1985-1998. J Gen Intern Med 2002; 17:165-172
12. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G: The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999; 19:132-140
13. Stein MB, Sherbourne CD, Craske MG, Means-Christensen A, Bystritsky A, Katon W, Sullivan G, Roy-Byrne PP: Quality of care for primary care patients with anxiety disorders. Am J Psychiatry 2004; 161:2230-2237
14. McManus P, Mant A, Mitchell P, Britt H, Dudley J: Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry 2003; 37:184-189
15. Donoghue JM, Tylee A: The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996; 168:164-168
16. Weisberg RB, Bruce SE, Machan JT, Kessler RC, Culpepper L, Keller MB: Nonpsychiatric illness among primary care patients with trauma histories and post-traumatic stress disorder. Psychiatr Serv 2002; 53:848-854
17. Weisberg RB, Maki KM, Culpepper L, Keller MB: Is anyone really M.A.D.? the occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patients. J Nerv Ment Dis 2005; 193:223-230
18. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for the DSM-IV Axis I Disorders. New York, New York State Psychiatric Institute, Biometrics Research Department, 1996
19. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Press, 1994
20. Keller MB, Warshaw MG, Dyck I, Dolan RT, Shea MY, Riley K, Shapiro R: LIFE-IV: The Longitudinal Interval Follow-up Evaluation for DSM-IV. Providence, RI, Brown University, Department of Psychiatry and Human Behavior, 1997
21. Steketee G, Perry JC, Goisman RM, Warshaw MG, Massion AO, Peterson LG, Langford L, Weinshenker N, Farreras IG, Keller MB: The Psychosocial Treatments Interview for Anxiety Disorders: a method for assessing psychotherapeutic procedures in anxiety disorders. J Psychother Pract Res 1997; 6:194-210
22. Rickels K, Schweizer E, Lucki I: Benzodiazepine side effects, in American Psychiatric Association Annual Review, Vol 6. Edited by Hales RE, Frances AJ. Washington, DC, American Psychiatric Press, 1987, pp 781-801
23. Woods JH, Katz JL, Winger G: Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992; 44:151-347
24. Borus JF, Howes MJ, Devins NP, Rosenberg R, Livingston WW: Primary health care providers' recognition and diagnosis of mental disorders in their patients. Gen Hosp Psychiatry 1988; 10:317-321
25. Sleath BL, Rubin RH, Huston SA: Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Ann Pharmacother 2001; 35:419-423
26. Peveler R, George C, Kinmonth AL, Campbell M: Thompson C: Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999; 319:612-615